Lois M Ramondetta Selected Research

Intrauterine Devices (Intrauterine Device)

1/2021

Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lois M Ramondetta Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 09/2003
15	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022 - 06/2005
15	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 09/2002
7	Carcinoma (Carcinomatosis) 01/2019 - 10/2004
7	Ovarian Neoplasms (Ovarian Cancer) 06/2017 - 04/2006
3	Disease Progression 10/2017 - 02/2014
3	Chronic Disease (Chronic Diseases) 01/2017 - 07/2015
3	Neoplasm Metastasis (Metastasis) 10/2015 - 03/2004
3	Neutropenia 12/2012 - 05/2005
2	Nausea 01/2021 - 12/2010
2	Hyperplasia 01/2021 - 05/2005
2	Ovarian Epithelial Carcinoma 01/2019 - 10/2015
2	Fistula 10/2017 - 02/2014
2	Wounds and Injuries (Trauma) 10/2017 - 11/2003
2	Leiomyosarcoma 12/2016 - 06/2005
2	Adenocarcinoma 06/2013 - 09/2002
2	Anemia 12/2010 - 05/2005
2	Endometrial Stromal Sarcoma 05/2009 - 06/2005
2	Endometrial Hyperplasia 05/2005 - 09/2002
1	Vomiting 01/2021
1	Granulosa Cell Tumor 01/2021
1	Vaginal Neoplasms (Cancer, Vaginal) 01/2021
1	Carcinosarcoma 01/2018
1	Hemorrhage 10/2017
1	Thromboembolism 10/2017
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2017
1	Fallopian Tube Neoplasms 10/2015
1	Anaphylaxis (Anaphylactic Shock) 07/2015
1	Ovarian Diseases (Ovarian Disease) 01/2015
1	Body Weight (Weight, Body) 02/2014
1	Hypertension (High Blood Pressure) 02/2014
1	Obesity 04/2011
1	Insulin Resistance 04/2011
1	Fatigue 12/2010
1	Lymphopenia (Lymphocytopenia) 12/2010

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 09/2003
6	PlatinumIBA 04/2022 - 01/2004
5	Bevacizumab (Avastin)FDA Link 04/2022 - 02/2014
5	Adrenergic Agents (Adrenergic Drugs)IBA 07/2020 - 01/2013
4	Pharmaceutical PreparationsIBA 11/2020 - 12/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2017 - 02/2014
3	Topotecan (Hycamtin)FDA LinkGeneric 10/2017 - 02/2014
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2017 - 07/2015
3	Gemcitabine FDA Link 11/2010 - 01/2004
2	AntigensIBA 01/2022 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2017
2	pembrolizumabIBA 01/2021 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 02/2014
2	VaccinesIBA 05/2020 - 01/2015
2	amsonic acid (DAS)IBA 08/2015 - 07/2015
2	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2013 - 01/2013
2	Estrogens (Estrogen)FDA Link 04/2011 - 05/2005
2	Mifepristone (RU 486)FDA Link 05/2009 - 08/2008
2	Progesterone Receptors (Progesterone Receptor)IBA 05/2009 - 05/2005
2	Gefitinib (Iressa)FDA Link 03/2009 - 06/2008
2	Antineoplastic Agents (Antineoplastics)IBA 03/2009 - 06/2008
2	Phosphotransferases (Kinase)IBA 06/2005 - 10/2004
2	Imatinib Mesylate (Gleevec)FDA Link 06/2005 - 10/2004
2	Tyrosine (L-Tyrosine)FDA Link 06/2005 - 10/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Levonorgestrel (Plan B)FDA LinkGeneric 01/2021
1	Ondansetron (Zofran)FDA LinkGeneric 01/2021
1	lenvatinibIBA 01/2021
1	Granisetron (Kytril)FDA LinkGeneric 01/2021
1	AntiemeticsIBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2020
1	Hormones (Hormone)IBA 07/2020
1	Papillomavirus Vaccines (HPV Vaccines)IBA 05/2020
1	Propranolol (Inderal)FDA LinkGeneric 01/2019
1	CreatinineIBA 10/2017
1	env Gene ProductsIBA 01/2015
1	AntibodiesIBA 01/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2015
1	Pemetrexed (MTA)FDA Link 09/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2013
1	Cyclic AMP (AMP, Cyclic)IBA 01/2013
1	Albumin-Bound Paclitaxel FDA Link 12/2012
1	Drug CombinationsIBA 12/2012
1	130-nm albumin-bound paclitaxelIBA 12/2012
1	acivicin (AT 125)IBA 12/2012
1	Glucose (Dextrose)FDA LinkGeneric 04/2011
1	Insulin (Novolin)FDA Link 04/2011
1	Hematoxylin (Haematoxylon)IBA 12/2010
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2010

Therapy/Procedure

19	Therapeutics 01/2021 - 05/2005
17	Drug Therapy (Chemotherapy) 04/2022 - 03/2004
6	Radiotherapy 01/2018 - 03/2004
5	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 11/2010
5	Hysterectomy 10/2021 - 03/2004
3	Adjuvant Chemotherapy 05/2013 - 03/2004
2	Chemoradiotherapy 01/2022 - 01/2008
2	Terminal Care (Care, Terminal) 06/2017 - 10/2014
2	Palliative Care (Palliative Therapy) 01/2017 - 12/2015
2	Combination Drug Therapy (Combination Chemotherapy) 02/2014 - 11/2010
1	Complementary Therapies (Alternative Medicine) 01/2021
1	Intrauterine Devices (Intrauterine Device) 01/2021
1	Ambulatory Care (Outpatient Care) 01/2017
1	Hospice Care (Care, Bereavement) 11/2014
1	Pelvic Exenteration 09/2014
1	Drug Tapering 12/2012